CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-21 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −15,276 | 0 | ||
| 2022-10-21 | Nussbaum Ran Director | Option exercise | +47,999 | $5.94 | $285K | 1,481,927 |
| 2022-10-21 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −32,723 | 0 | ||
| 2022-10-21 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −15,276 | 0 | ||
| 2022-09-14 | Belldegrun Arie Director | Option exercise | +160,000 | $5.00 | $800K | 408,693 |
| 2022-09-14 | Belldegrun Arie Director | Option exercise · Stock Option (right to buy) | −160,000 | 0 | ||
| 2022-09-08 | WEN LEANA Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-08-31 | Belldegrun Arie Director | Option exercise | +3,241 | $5.00 | $16K | 248,693 |
| 2022-08-31 | Belldegrun Arie Director | Option exercise · Stock Option (right to buy) | −3,241 | 0 | ||
| 2022-08-31 | Smith Jason Drew General Counsel | Option exercise | +8,333 | 15,782 | ||
| 2022-08-31 | Smith Jason Drew General Counsel | Sale | −3,606 | $7.21 | $26K | 12,176 |
| 2022-08-31 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −8,333 | 8,334 | ||
| 2022-08-01 | Schoenberg Mark Chief Medical Officer | Sale | −259 | $7.81 | $2K | 23,708 |
| 2022-07-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +500 | 23,967 | ||
| 2022-07-31 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −500 | 1,000 | ||
| 2022-06-16 | Nussbaum Ran Director | Option exercise | +2,211 | $5.00 | $11K | 1,437,169 |
| 2022-06-16 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −2,211 | 0 | ||
| 2022-06-08 | Belldegrun Arie Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2022-06-08 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2022-06-06 | Nussbaum Ran Director | Option exercise | +1,030 | $5.00 | $5K | 1,434,958 |
Page 12 of 13 · 244 trades